CryoLife, Inc. (CRY) EPS Estimated At $0.06

October 2, 2018 - By Ruchi Gupta

CryoLife, Inc. (NYSE:CRY) LogoInvestors sentiment increased to 1.67 in 2018 Q2. Its up 0.82, from 0.85 in 2018Q1. It increased, as 6 investors sold CryoLife, Inc. shares while 30 reduced holdings. 15 funds opened positions while 45 raised stakes. 24.77 million shares or 2.42% more from 24.19 million shares in 2018Q1 were reported.
Wells Fargo & Mn holds 0% or 59,843 shares. Deutsche Bank Ag accumulated 70,641 shares. Swiss National Bank & Trust has 58,500 shares for 0% of their portfolio. State Teachers Retirement Systems reported 0.01% of its portfolio in CryoLife, Inc. (NYSE:CRY). Moreover, Elk Creek Prtn Ltd Company has 0.52% invested in CryoLife, Inc. (NYSE:CRY). Parametric Port Assocs Lc stated it has 57,937 shares or 0% of all its holdings. Citigroup holds 0% or 5,049 shares. Renaissance Ltd Liability reported 638,800 shares. Ubs Asset Mgmt Americas Inc holds 12,179 shares or 0% of its portfolio. 3.06M were accumulated by Capital Research Investors. Macquarie Limited holds 1.72 million shares or 0.08% of its portfolio. Us Bancorp De owns 0% invested in CryoLife, Inc. (NYSE:CRY) for 2,262 shares. Goldman Sachs Gp Inc holds 0% of its portfolio in CryoLife, Inc. (NYSE:CRY) for 136,956 shares. Penn Management holds 0.17% or 81,045 shares in its portfolio. Connors Investor accumulated 91,805 shares or 0.36% of the stock.

Since April 17, 2018, it had 0 insider buys, and 26 selling transactions for $9.94 million activity. Shares for $4.82M were sold by Mackin James P on Monday, August 13. Another trade for 2,256 shares valued at $63,168 was sold by Horton Amy. Davis John E had sold 4,373 shares worth $122,444 on Friday, June 1. LEE DAVID ASHLEY sold 10,000 shares worth $256,999. 6,332 shares valued at $215,921 were sold by Capps Scott B on Thursday, August 30. $325,433 worth of CryoLife, Inc. (NYSE:CRY) was sold by MORGAN HARVEY.

Analysts expect CryoLife, Inc. (NYSE:CRY) to report $0.06 EPS on October, 29.They anticipate $0.02 EPS change or 25.00 % from last quarter’s $0.08 EPS. CRY’s profit would be $2.21 million giving it 141.79 P/E if the $0.06 EPS is correct. After having $0.10 EPS previously, CryoLife, Inc.’s analysts see -40.00 % EPS growth. The stock decreased 3.32% or $1.17 during the last trading session, reaching $34.03. About 138,654 shares traded or 1.92% up from the average. CryoLife, Inc. (NYSE:CRY) has risen 50.44% since October 2, 2017 and is uptrending. It has outperformed by 34.82% the S&P500.

CryoLife, Inc., together with its subsidiaries, makes and distributes medical devices worldwide. The company has market cap of $1.25 billion. It also processes and distributes implantable human tissues for use in cardiac and vascular surgeries. It currently has negative earnings. The firm operates in two divisions, Medical Devices and Preservation Services.

Another recent and important CryoLife, Inc. (NYSE:CRY) news was published by Investorplace.com which published an article titled: “17 Small-Cap Stocks That Could Double” on October 01, 2018.

CryoLife, Inc. (NYSE:CRY) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>